Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Int. J. Mol. Sci. 2013, 14(4), 7480-7491; doi:10.3390/ijms14047480
Article

Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: A Potential Risk Factor Determinant for Type 2 Diabetic Retinopathy

1
, 1
, 2
 and 1,*
Received: 20 February 2013; in revised form: 8 March 2013 / Accepted: 21 March 2013 / Published: 3 April 2013
(This article belongs to the Special Issue Oxidative Stress and Ageing)
View Full-Text   |   Download PDF [491 KB, uploaded 19 June 2014]
Abstract: This study aims to investigate potential diabetic retinopathy (DR) risk factors by evaluating the circulating levels of pentosidine, soluble receptor for advanced glycation end-product (sRAGE), advanced oxidation protein product (AOPP) as well as glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities in DR patients. A total of 235 healthy controls, 171 type 2 diabetic without retinopathy (DNR) and 200 diabetic retinopathy (DR) patients were recruited. Plasma was extracted for the estimation of pentosidine, sRAGE, AOPP levels and GPx activity whereas peripheral blood mononuclear cells were disrupted for SOD activity measurement. DNR and DR patients showed significantly higher levels of plasma pentosidine, sRAGE and AOPP but lower GPx and SOD activities when compared to healthy controls. The sRAGE/pentosidine ratio in DR patients was significantly lower than the ratio detected in DNR patients. Proliferative DR patients had significantly higher levels of plasma pentosidine, sRAGE, AOPP and sRAGE/pentosidine ratio than non-proliferative DR patients. High HbA1c level, long duration of diabetes and low sRAGE/pentosidine ratio were determined as the risk factors for DR. This study suggests that sRAGE/pentosidine ratio could serve as a risk factor determinant for type 2 DR as it has a positive correlation with the severity of DR.
Keywords: advanced oxidation protein product; antioxidant enzymes; diabetic retinopathy; oxidative stress; pentosidine; risk factor; soluble receptor for advanced glycation end-product advanced oxidation protein product; antioxidant enzymes; diabetic retinopathy; oxidative stress; pentosidine; risk factor; soluble receptor for advanced glycation end-product
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ng, Z.X.; Chua, K.H.; Iqbal, T.; Kuppusamy, U.R. Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: A Potential Risk Factor Determinant for Type 2 Diabetic Retinopathy. Int. J. Mol. Sci. 2013, 14, 7480-7491.

AMA Style

Ng ZX, Chua KH, Iqbal T, Kuppusamy UR. Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: A Potential Risk Factor Determinant for Type 2 Diabetic Retinopathy. International Journal of Molecular Sciences. 2013; 14(4):7480-7491.

Chicago/Turabian Style

Ng, Zhi X.; Chua, Kek H.; Iqbal, Tajunisah; Kuppusamy, Umah R. 2013. "Soluble Receptor for Advanced Glycation End-Product (sRAGE)/Pentosidine Ratio: A Potential Risk Factor Determinant for Type 2 Diabetic Retinopathy." Int. J. Mol. Sci. 14, no. 4: 7480-7491.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert